Mina Sooch - Jan 10, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: President and CEO, Director
Signature: /s/ Emily J. Johns, by Power of Attorney
Stock symbol: OCUP
Transactions as of: Jan 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/12/2023, 05:08 PM
Previous filing: Feb 14, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+134K	+45.42%	$0.00	431K	Jan 10, 2023	Direct	F1
holding	OCUP	Common Stock						50K	Jan 10, 2023	By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+202K		$0.00	202K	Jan 10, 2023	Common Stock	202K	$3.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023.
F2	The option will vest with respect to 50,420 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.